5-ALA (Gliolan)

DRUG3 trials

Sponsors

Constantinos Hadjipanayis, University College, London, Hospices Civils de Lyon

Conditions

Benign Neoplasms, BrainBrain CancerBrain Neoplasms, BenignBrain Neoplasms, MalignantBrain TumorBrain Tumor, PrimaryBrain Tumor, RecurrentBrain Tumors

Phase 2

More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery

WithdrawnNCT01445691

Constantinos HadjipanayisBenign Neoplasms, Brain, Brain Cancer, Brain Neoplasms, Benign +12

Start: 2015-11-30End: 2016-09-30Updated: 2016-05-17

The Use of 5-ALA in Paediatric Patients With High Grade Brain Tumours

Not yet recruitingNCT06678867

University College, LondonBrain Tumor

Start: 2025-03-25End: 2026-12-30Target: 80Updated: 2025-03-27

Fluorescence Guided Focal Cortical Dysplasia Surgery

Not yet recruitingNCT07657975

Hospices Civils de LyonDrug Resistant Epilepsy

Start: 2026-09-01End: 2028-09-01Target: 5Updated: 2026-06-18